Samsung Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samsung Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
Sinil Pharmaceutical Co Ltd
sales of 50.21 billion Korean Won [US$47.05 million]
Pharma Reaserch Products Co Ltd
(45.95 billion Korean Won [US$43.06 million]
Humedix Co Ltd
(47.13 billion Korean Won [US$44.16 million]
During the year ended December of 2016, sales at
Samsung Pharmaceutical Co Ltd were 48.22 billion Korean Won (US$45.19 million).
increase of 14.4%
versus 2015, when the company's sales were 42.16 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Samsung Pharmaceutical Co Ltd had sales
of 44.08 billion Korean Won.